We are live on ! Find out more
PBE icon

Invesco Biotechnology & Genome ETF
PBE

82 hedge funds and large institutions have $133M invested in Invesco Biotechnology & Genome ETF in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 18

0.37% more ownership

Funds ownership: 30.5% → 30.87% (+0.37%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 86 → 82 (-4)

15% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 13

22% less capital invested

Capital invested by funds: $170M → $133M (-$36.9M)

Holders
82
Holders Change
-4
Holders Change %
-4.65%
% of All Funds
2.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
27
Reduced
18
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.63M
2
FIM
Freedom Investment Management
Connecticut
+$2.05M
3
Jane Street
Jane Street
New York
+$2.04M
4
VKH
Virtu KCG Holdings
New York
+$1.59M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.5M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$5.07M
2
Morgan Stanley
Morgan Stanley
New York
-$4M
3
UBS Group
UBS Group
Switzerland
-$2.96M
4
FAAS
First Allied Advisory Services
California
-$2.66M
5
Wells Fargo
Wells Fargo
California
-$750K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAN
51
Cetera Advisor Networks
California
$264K +$20.9K +374 +7%
PJSIMP
52
P.J. Schmidt Investment Management (PJS)
Wisconsin
$238K -$39.1K -700 -12%
WA
53
WBH Advisory
Maryland
$226K +$56 +1 +0%
DWM
54
Dorchester Wealth Management
Quebec, Canada
$220K – – –
WEC
55
Winslow Evans & Crocker
Massachusetts
$159K +$1.01K +18 +0.5%
JWM
56
Jacobus Wealth Management
Wisconsin
$144K – – –
GT
57
Glenmede Trust
Pennsylvania
$72K – – –
BC
58
Bartlett & Co
Ohio
$46K – – –
PNC Financial Services Group
59
PNC Financial Services Group
Pennsylvania
$43K +$2.79K +50 +6%
WA
60
WFG Advisors
Texas
$33K – – –
FCCM
61
First City Capital Management
Georgia
$28.6K +$34.9K +625 New
CFA
62
CT Financial Advisors
Pennsylvania
$27.3K +$112 +2 +0.3%
LFR
63
Lehman Financial Resources
Pennsylvania
$27K – – –
MCM
64
Manchester Capital Management
Vermont
$25K – – –
BCM
65
Blume Capital Management
California
$16K – – –
PSI
66
Pinnacle Summer Investments
Virginia
$16K +$19.6K +350 New
RFA
67
Reilly Financial Advisors
California
$14K – – –
TFA
68
Transamerica Financial Advisors
Florida
$14K – – –
NFG
69
Next Financial Group
Texas
$13K – – –
DADC
70
D.A. Davidson & Co
Montana
$12K – – –
AIP
71
Ameritas Investment Partners
Nebraska
$11K – – –
ASN
72
Advisory Services Network
Georgia
$9K -$97.1K -1,737 -90%
JFGIW
73
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$9K +$1.23K +22 +13%
Creative Planning
74
Creative Planning
Kansas
$9K +$11.2K +200 New
RPG
75
Risk Paradigm Group
Texas
$8.41K +$10.3K +184 New
1 2
3
4

PBE Hedge Fund Activity: Q3 2015 in Review

82 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Invesco Biotechnology & Genome ETF (PBE) for Q3 2015, worth a combined $133M — down 22% from $170M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of PBE and 11 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 27 added.

The largest buyer was Susquehanna International Group, adding an estimated $2.63M. The largest seller was Bank of America, cutting an estimated $5.07M.

  • 82 institutional investors held Invesco Biotechnology & Genome ETF (PBE) as of Q3 2015, down from 86 in Q2 2015.
  • Funds reported $133M of Invesco Biotechnology & Genome ETF stock for Q3 2015, down 22% quarter-over-quarter.
  • 11 funds opened new Invesco Biotechnology & Genome ETF positions in Q3 2015 and 13 closed out, a net change of -2 holders.
  • The largest Invesco Biotechnology & Genome ETF buyer in Q3 2015 was Susquehanna International Group, an estimated $2.63M added.
  • The largest Invesco Biotechnology & Genome ETF seller in Q3 2015 was Bank of America, an estimated $5.07M sold.

Based on aggregated 13F filings for Q3 2015.